Poster Proposal | PICO Format

Running Head: POSTER PROPOSAL
POSTER PROPOSAL
Name of the Student
Name of the University
Author’s Note

POSTER PROPOSAL1
The clinical question for this poster under the PICO format is:
P- Population/patient: The use of Botox therapy for people above the age of 65 in long term care
facility (LTC).
I-Intervention: Botox injection for muscle stiffness.
C- Comparison/Control: Leg brace, not a candidate for surgery.
O- Outcome: Alleviate pain and muscle tenderness during care.
Search Strategy
The topic was chosen after searching for several nursing literature databases that was related to
the area of specialization. The search terms were used, such as Botulinum, geriatrics, evidence
based practice, nursing practice, Botox therapy, muscle contractions in old age, treatment for
muscle contraction, PICO format for clinical research, spasticity and nursing interventions in
geriatrics. The databases used were Pubmed, CINAHL, CNA, Canadian Journal of Nursing
Research and The National Nursing Database (NCSBN) that gave the topic for research.
The results which were collected gave the idea that Botox is used for several cosmetic
procedures, which includes the injections of botulinum toxin type A also known as BTX-A that
is used widely for the cosmetic related treatments in Canada and USA. It got legally approved
after it was verified by Food and Drug Administration (FDA) for the treatment of glabellar lines.
It is an appreciated route of treatment because it is minimally invasive, easy to administer and
with a quick recovery speed. The filters used were 2014-2019 and the country chosen was
Canada. The criteria that excluded the papers in the review was if the paper focused on other
treatment procedures other than the muscle contraction in older people.

POSTER PROPOSAL2
Critical annotations
Jankovic, J. (2018). An update on new and unique uses of botulinum toxin in movement
disorders. Toxicon, 147, 84-88.
The use of botulinum toxin is used in several therapeutic treatments after it is was approved by
FDA in 1989. It is utilized for the treatment of several movement disorders such as bruxism,
oromandibular dystonia, anterocollis, tremors, levodopa-induced dyskinesia, tardives and restless
leg syndrome. There are several benefits for the patient when it comes to the treatment of such
conditions as it is considered to be safe.
Shaikh, A., Phadke, C. P., Ismail, F., & Boulias, C. (2016). Relationship between botulinum
toxin, spasticity, and pain: a survey of patient perception. Canadian Journal of
Neurological Sciences, 43(2), 311-315.
This study focuses on the use of botulinum toxin type A (BoNTA) for the pain management in
people who have the issue of spasticity. The result of the research justifies that the pain related to
the movement disorders can be treated if BoNTA treatment is used such as the injection.
Kinnear, B. Z., Lannin, N. A., Cusick, A., Harvey, L. A., & Rawicki, B. (2014).
Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a
systematic review. Physical therapy, 94(11), 1569-1581.
Impairment in the central nervous system disorder causes spasm in people, which is a motor
disorder that affects the reflexes and muscle tones. The use of traditional rehabilitation for
spasticity are pharmacotherapy such as botulinum toxin A, occupational therapy and physical
therapy.